Citadel Investment Advisory’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Sell
3,486
-5
-0.1% -$2.8K 0.83% 26
2026
Q1
$1.96M Sell
3,491
-191
-5% -$122K 0.94% 23
2025
Q4
$2.35M Hold
3,682
1.01% 22
2025
Q3
$2.35M Hold
3,682
1.08% 21
2025
Q2
$1.98M Buy
3,682
+47
+1% +$22.5K 0.96% 23
2025
Q1
$1.53M Sell
3,635
-25
-0.7% -$10.9K 0.75% 27
2024
Q4
$1.51M Sell
3,660
-25
-0.7% -$11K 0.78% 27
2024
Q3
$1.86M Sell
3,685
-10
-0.3% -$4.86K 0.98% 26
2024
Q2
$1.8M Hold
3,695
1.02% 24
2024
Q1
$2M Sell
3,695
-10
-0.3% -$5.46K 1.12% 22
2023
Q4
$2.06M Hold
3,705
1.26% 21
2023
Q3
$1.62M Hold
3,705
1.06% 22
2023
Q2
$1.86M Hold
3,705
1.2% 20
2023
Q1
$1.85M Sell
3,705
-110
-3% -$52.6K 1.26% 21
2022
Q4
$1.56M Sell
3,815
-140
-4% -$54.3K 1.06% 22
2022
Q3
$1.29M Hold
3,955
0.98% 22
2022
Q2
$1.39M Hold
3,955
0.94% 25
2022
Q1
$2.16M Hold
3,955
1.26% 19
2021
Q4
$2.6M Sell
3,955
-120
-3% -$75.3K 1.52% 18
2021
Q3
$2.53M Hold
4,075
1.57% 16
2021
Q2
$2.57M Sell
4,075
-50
-1% -$27.6K 1.59% 17
2021
Q1
$2.02M Hold
4,125
1.32% 18
2020
Q4
$2.06M Buy
+4,125
New +$1.85M 1.47% 17

Other funds holding IDXX

Citadel Investment Advisory's IDXX Position: Q2 2026 in Review

Citadel Investment Advisory reduced its Idexx Laboratories (IDXX) stake by 0.14% in Q2 2026, selling an estimated $2.8K and leaving 3,486 shares worth $1.83M. The position accounts for 0.83% of the portfolio, ranked #26.

Citadel Investment Advisory first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.6M in Q4 2021. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Citadel Investment Advisory held 3,486 shares of Idexx Laboratories worth $1.83M as of Q2 2026.
  • Citadel Investment Advisory sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
  • Idexx Laboratories made up 0.83% of Citadel Investment Advisory's portfolio in Q2 2026, its #26 holding.
  • Citadel Investment Advisory first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Citadel Investment Advisory's Idexx Laboratories position peaked at $2.6M in Q4 2021.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.